Gene: CCDC106
Official Full Name: coiled-coil domain containing 106provided by HGNC
Gene Summary: Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26968 | CCDC106 Knockout cell line (HeLa) | Human | CCDC106 | 1:3~1:6 | Negative | Online Inquiry |
KO26969 | CCDC106 Knockout cell line (HEK293) | Human | CCDC106 | 1:3~1:6 | Negative | Online Inquiry |
KO26970 | CCDC106 Knockout cell line (A549) | Human | CCDC106 | 1:3~1:4 | Negative | Online Inquiry |
CCDC106 gene knockout cell lines are specifically designed cellular models in which the CCDC106 gene has been selectively disrupted, allowing researchers to investigate the gene's biological functions and contributions to various cellular processes. By employing advanced CRISPR-Cas9 genome editing technology, these cell lines provide a powerful tool for elucidating the role of CCDC106 in cellular mechanisms such as proliferation, differentiation, and apoptosis.
The key function of CCDC106 knockout cell lines lies in their ability to mimic the functional deficiencies of CCDC106, thereby facilitating comprehensive studies on its involvement in disease pathogenesis. Precise gene disruption leads to observable phenotypic changes, enabling scientists to examine how the absence of CCDC106 impacts cellular behavior under different experimental conditions. This is particularly relevant in the fields of developmental biology and cancer research, where understanding gene function can unveil novel therapeutic targets.
From a scientific perspective, CCDC106 knockout cell lines are vital in exploring gene-gene interactions and signaling pathways, providing insights that are essential for both basic and applied research. They are commonly utilized in drug discovery and development, as understanding the knockout effects can lead to the identification of new biomarkers and potential therapeutic interventions.
One of the standout advantages of our CCDC106 knockout cell lines is their high specificity and reproducibility compared to conventional approaches, such as RNA interference. Unlike transient knockout methods that may yield variable results, these stable knockout cell lines provide consistent data and empower researchers with robust models for their studies.
For researchers and clinicians, investing in CCDC106 knockout cell lines can streamline experimental workflows and improve the quality of research outcomes. Additionally, they offer the potential to uncover novel insights into human diseases associated with CCDC106 dysfunction, making them invaluable for advancing both fundamental and translational research efforts.
As a leader in the field of biological products, our company is committed to providing high-quality, innovative tools tailored for the scientific community, ensuring that your research is backed by excellence and expertise.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.